Arkansas Cancer Research Center

Little Rock, Arkansas 72205

0 studies enrolling now · 5 studies all time

What they study most

Breast Cancer, Colonic Neoplasms, Colorectal Neoplasms, Multiple Myeloma, Prostate Cancer, Rectal Neoplasms, Refractory Plasma Cell Neoplasm, Stage II Multiple Myeloma, Stage III Multiple Myeloma

Studies at this site

• Vaccine Therapy in Treating Patients With Multiple Myeloma — Completed
• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer — Completed
• A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and Capecitabine — Completed
• Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple Myeloma — Completed
• GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer — Stopped early